IL126892A - Pharmaceutical compositions for the sustained release of at least one water-insoluble active principle - Google Patents

Pharmaceutical compositions for the sustained release of at least one water-insoluble active principle

Info

Publication number
IL126892A
IL126892A IL12689297A IL12689297A IL126892A IL 126892 A IL126892 A IL 126892A IL 12689297 A IL12689297 A IL 12689297A IL 12689297 A IL12689297 A IL 12689297A IL 126892 A IL126892 A IL 126892A
Authority
IL
Israel
Prior art keywords
pharmaceutical composition
fact
composition according
active principle
approximately
Prior art date
Application number
IL12689297A
Other languages
English (en)
Other versions
IL126892A0 (en
Original Assignee
Debio Rech Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Debio Rech Pharma Sa filed Critical Debio Rech Pharma Sa
Publication of IL126892A0 publication Critical patent/IL126892A0/xx
Publication of IL126892A publication Critical patent/IL126892A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL12689297A 1996-05-06 1997-04-28 Pharmaceutical compositions for the sustained release of at least one water-insoluble active principle IL126892A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9605630A FR2748205A1 (fr) 1996-05-06 1996-05-06 Compositions pharmaceutiques pour la liberation controlee de principes actifs insolubles
PCT/EP1997/002187 WO1997041836A1 (fr) 1996-05-06 1997-04-28 Compositions pharmaceutiques pour la liberation prolongee de principes actifs insolubles

Publications (2)

Publication Number Publication Date
IL126892A0 IL126892A0 (en) 1999-09-22
IL126892A true IL126892A (en) 2004-07-25

Family

ID=9491862

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12689297A IL126892A (en) 1996-05-06 1997-04-28 Pharmaceutical compositions for the sustained release of at least one water-insoluble active principle

Country Status (9)

Country Link
US (1) US6245346B1 (ja)
EP (1) EP0896527A1 (ja)
JP (1) JP2000509403A (ja)
AU (1) AU710539B2 (ja)
CA (1) CA2253377A1 (ja)
FR (1) FR2748205A1 (ja)
IL (1) IL126892A (ja)
NO (1) NO985145L (ja)
WO (1) WO1997041836A1 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10024451A1 (de) 2000-05-18 2001-11-29 Asta Medica Ag Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
WO2002058671A1 (en) * 2001-01-26 2002-08-01 Debio Recherche Pharmaceutique S.A. Burst free pharmaceutical microparticules
JP2004535431A (ja) 2001-06-22 2004-11-25 サザン バイオシステムズ， インコーポレイテッド ゼロ次長期放出同軸インプラント
GB0122113D0 (en) * 2001-09-11 2001-10-31 Astrazeneca Ab Composition
US6987111B2 (en) * 2003-08-06 2006-01-17 Alkermes Controlled Therapeutics, Ii Aripiprazole, olanzapine and haloperidol pamoate salts
AU2005325213B2 (en) 2004-08-04 2010-10-07 Evonik Corporation Methods for manufacturing delivery devices and devices thereof
EP1969940A3 (en) 2004-12-17 2008-12-10 Devgen NV Nematicidal compositions
US8882747B2 (en) * 2005-11-09 2014-11-11 The Invention Science Fund I, Llc Substance delivery system
CA2709712C (en) 2007-12-20 2016-05-10 Surmodics Pharmaceuticals, Inc. Process for preparing microparticles having a low residual solvent volume
US8604101B2 (en) * 2010-03-24 2013-12-10 Basf Se Process for producing aqueous dispersions of thermoplastic polyesters
BR112012023413A2 (pt) 2010-03-24 2018-05-08 Basf Se processo para produzir dispersões aquosas de polímeros termoplásticos, dispersão aquosa de polímero, uso de uma dispersão aquosa de polímero, e, poliéster termoplástico.
EP2598553B1 (en) * 2010-07-26 2016-04-27 Université de Genève Compositions comprising polymers prepared from 2-hydroxyalkyl acids
WO2013041649A1 (de) 2011-09-23 2013-03-28 Basf Se Verwendung einer wässrigen dispersion biologisch abbaubarer polyester
CN106456704A (zh) 2014-04-16 2017-02-22 Veyx-药物有限公司 兽药组合物和其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4622244A (en) * 1979-09-04 1986-11-11 The Washington University Process for preparation of microcapsules
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
CH679207A5 (ja) 1989-07-28 1992-01-15 Debiopharm Sa
GB2246514B (en) * 1990-08-01 1993-12-15 Scras Sustained release pharmaceutical compositions and the preparation of particles for use therein
ES2062634T3 (es) * 1990-08-30 1994-12-16 Senju Pharma Co Composicion con liberacion controlada del farmaco.
CA2148823C (en) * 1992-11-17 1999-03-09 Welfide Corporation Sustained release microsphere preparation containing antipsychotic drug and production process thereof
AU3533395A (en) * 1994-09-30 1996-04-26 Takeda Chemical Industries Ltd. Oral sustained-release preparation
US5869079A (en) * 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents

Also Published As

Publication number Publication date
IL126892A0 (en) 1999-09-22
NO985145D0 (no) 1998-11-04
AU2773597A (en) 1997-11-26
JP2000509403A (ja) 2000-07-25
CA2253377A1 (fr) 1997-11-13
US6245346B1 (en) 2001-06-12
WO1997041836A1 (fr) 1997-11-13
FR2748205A1 (fr) 1997-11-07
EP0896527A1 (fr) 1999-02-17
NO985145L (no) 1998-11-04
AU710539B2 (en) 1999-09-23

Similar Documents

Publication Publication Date Title
DE69728371T2 (de) Verfahren zur herstellung von implantaten, die leuprolid enthalten
DE69332210T2 (de) Biologisch abbaubares, schmelzgesponnenes abgabesystem zur kontrollierten freisetzung
CA2125148C (en) A carbohydrate glass matrix for the sustained release of a therapeutic agent
DE3853853T2 (de) Verabreichungsformen für Pharmaka.
US5419910A (en) Growth promoters for animals
AU779938B2 (en) Compressed microparticles for dry injection
US5192741A (en) Sustained and controlled release of water insoluble polypeptides
EP1484033B1 (en) Liquid polymeric compositions for controlled release of bioactive substances
US4650665A (en) Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
US4568536A (en) Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
AU710539B2 (en) Pharmaceutical compositions for the sustained release of insoluble active principles
US20210212934A1 (en) Methods for providing long-lasting anesthetic effect using microparticles
EP0158277A2 (de) Implantierbare Zubereitungen von regulatorischen Peptiden mit gesteuerter Freisetzung und Verfahren zur ihrer Herstellung
CZ20031124A3 (cs) Polymerní formulace leuprolidu pro podání se zlepšenou účinností
JP2003517014A (ja) 即放性および徐放性成分を含有する医薬インプラントおよび投与方法
CH683749A5 (de) Pharmazeutische Nasalzusammensetzung.
TWI399224B (zh) 含有曲普瑞林醋酸鹽之固體持續釋放調配物
AU2008259411B2 (en) Slow release pharmaceutical composition made of microparticles
US5643595A (en) Growth promoters for animals
GB1573459A (en) Absorbable polymer drug compositions
EP0275961B1 (de) Perorale Arzneimittelzubereitung mit verzögerter Wirkstofffreigabe
KR20240056731A (ko) 항정신병 주사용 서방형 조성물
WO1999051201A1 (en) Sustained release formulation
AU777393B2 (en) Improved growth stimulant compositions
Faraja et al. Preparation, In Vitro and In Vivo Studies of Vitamin B12 Loaded Implants

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees